A clinical trial in healthy volunteers and patients with mild asthma to investigate a new medicine (AZD4604) for the treatment of asthma

Trial Identifier:	D8210C00001
Sponsor:	AstraZeneca
NCTID::	NCT04769869
Start Date:	July 2022
Primary Completion Date:	January 2023
Study Completion Date:	January 2023
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Belfast, GB, BT9 6AD
GB	Cambridge, GB, CB2 0AU
GB	Harrow, GB, HA1 3UJ
GB	London, GB, SE1 1YR
GB	Manchester, GB, M23 9QZ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company